CATHY TAYLOR: Open Payments
NPI 1063196236 · SPRING, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,087 in 101 payments from 11 companies in 2025. Trend: 2023 $222 · 2024 $1,146 · 2025 $2,087
Food & beverage: $2,087
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 21 | $476 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 19 | $366 |
| Neurocrine BioSciences, Inc. | 14 | $341 |
| Takeda Pharmaceuticals U.S.A., Inc. | 16 | $291 |
| Janssen Pharmaceuticals, Inc | 5 | $216 |
| ABBVIE INC. | 13 | $153 |
| Axsome Therapeutics, Inc. | 6 | $116 |
| Collegium Pharmaceutical, Inc. | 4 | $67 |
| Teva Pharmaceuticals USA, Inc. | 1 | $24 |
| Lundbeck LLC | 1 | $23 |
Products named: REXULTI, CAPLYTA, INGREZZA, ENTYVIO, SPRAVATO, VRAYLAR, Auvelity, Jornay PM.
Industry payments across TX — which companies pay providers there.
